MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series C
Alto Neuroscience, Inc. (NYSE:ANRO)*
Organization & Developments: Alto Neuroscience
Parents
Alto Neuroscience, Inc. (NYSE:ANRO)*
Children
*Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions.
2021: Mental health startup Cerebral teams with Alto Neuroscience to bring 'precision psychiatry' to patients' homes
2024: Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder
2024: Alto Neuroscience Starts IPO Plan For CNS Disorder Treatments_seekingalpha.com
2025: Alto misses primary efficacy endpoint in phase 2 depression trial
2026: Alto Neuroscience: 4 Shots At Success In CNS Diseases In 2026
Jumps
Finance & Acquisitions: Alto Neuroscience
Key People: Alto Neuroscience